# Testosterone Treatment in Men With Chronic Kidney Disease

> **NCT05249634** · PHASE2 · RECRUITING · sponsor: **St. Louis University** · enrollment: 20 (estimated)

## Conditions studied

- Hypogonadism, Male
- Kidney Disease, Chronic

## Interventions

- **DRUG:** Jatenzo Pill

## Key facts

- **NCT ID:** NCT05249634
- **Lead sponsor:** St. Louis University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-15
- **Primary completion:** 2028-06
- **Final completion:** 2028-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05249634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05249634, "Testosterone Treatment in Men With Chronic Kidney Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05249634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*